Literature DB >> 18758965

Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma.

Michael Kent1, David Rice, Raja Flores.   

Abstract

OPINION STATEMENT: The clinical presentation of malignant pleural mesothelioma (MPM) is nonspecific. The process to obtain the correct diagnosis can be challenging and requires a high index of suspicion. Once the diagnosis is made, there is no universally accepted standard of care and treatment decisions are strongly influenced by physician bias. Physicians who see few numbers of patients tend to treat based on symptoms alone by drainage of the pleural effusion and talc pleurodesis, while physicians at several tertiary referral centers tend to take an aggressive multimodality approach incorporating surgical resection, chemotherapy, and radiation. The primary goal of surgery in this setting is the resection of all gross disease. The choice of operation, extrapleural pneumonectomy (EPP) or pleurectomy/decortication (P/D), depends on disease stage, pulmonary function, philosophy of the treating physician, and type of planned adjuvant therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18758965     DOI: 10.1007/s11864-008-0070-4

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  23 in total

1.  Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.

Authors:  R T Heelan; V W Rusch; C B Begg; D M Panicek; J F Caravelli; C Eisen
Journal:  AJR Am J Roentgenol       Date:  1999-04       Impact factor: 3.959

2.  Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.

Authors:  E G Butchart; T Ashcroft; W C Barnsley; M P Holden
Journal:  Thorax       Date:  1976-02       Impact factor: 9.139

3.  Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.

Authors:  D J Sugarbaker; R M Flores; M T Jaklitsch; W G Richards; G M Strauss; J M Corson; M M DeCamp; S J Swanson; R Bueno; J M Lukanich; E H Baldini; S J Mentzer
Journal:  J Thorac Cardiovasc Surg       Date:  1999-01       Impact factor: 5.209

4.  The clinical aspects of mesothelioma.

Authors:  P C Elmes; J C Simpson
Journal:  Q J Med       Date:  1976-07

5.  Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma.

Authors:  C Boutin; J R Viallat; N Van Zandwijk; J T Douillard; J C Paillard; J C Guerin; P Mignot; J Migueres; F Varlet; A Jehan
Journal:  Cancer       Date:  1991-04-15       Impact factor: 6.860

6.  Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma.

Authors:  H I Pass; B K Temeck; K Kranda; G Thomas; A Russo; P Smith; W Friauf; S M Steinberg
Journal:  Ann Surg Oncol       Date:  1997-12       Impact factor: 5.344

7.  Positron emission tomography predicts survival in malignant pleural mesothelioma.

Authors:  Raja M Flores; Timothy Akhurst; Mithat Gonen; Maureen Zakowski; Joseph Dycoco; Steven M Larson; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2006-10       Impact factor: 5.209

8.  A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.

Authors:  V W Rusch; K Rosenzweig; E Venkatraman; L Leon; A Raben; L Harrison; M S Bains; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  2001-10       Impact factor: 5.209

9.  Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.

Authors:  Raja M Flores; Timothy Akhurst; Mithat Gonen; Steven M Larson; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2003-07       Impact factor: 5.209

10.  Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

Authors:  Raja M Flores; Harvey I Pass; Venkatraman E Seshan; Joseph Dycoco; Maureen Zakowski; Michele Carbone; Manjit S Bains; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2008-02-14       Impact factor: 5.209

View more
  8 in total

1.  Positron emission tomography in mesothelioma patients.

Authors:  Gaia Grassetto; Domenico Rubello
Journal:  Mol Imaging Biol       Date:  2009-03-25       Impact factor: 3.488

2.  [Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg].

Authors:  M Ried; U Speth; T Potzger; R Neu; C Diez; M Klinkhammer-Schalke; H-S Hofmann
Journal:  Chirurg       Date:  2013-11       Impact factor: 0.955

3.  Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy/decortication.

Authors:  William F Sensakovic; Samuel G Armato; Adam Starkey; Hedy L Kindler; Wickii T Vigneswaran
Journal:  Acad Radiol       Date:  2010-12-10       Impact factor: 3.173

4.  Interobserver Variability of Quantitative and Qualitative Assessment Using MRI in Malignant Pleural Mesothelioma.

Authors:  Ritu R Gill; David J Murphy; Ravi T Seethamraju; Emanuele Mazzola; Raphael Bueno; William G Richards
Journal:  Radiol Cardiothorac Imaging       Date:  2020-04-30

Review 5.  Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.

Authors:  Lisa Brusselmans; Lieselot Arnouts; Charissa Millevert; Joyce Vandersnickt; Jan P van Meerbeeck; Kevin Lamote
Journal:  Transl Lung Cancer Res       Date:  2018-10

6.  Diagnostic value of mesothelin in pleural fluids: comparison with CYFRA 21-1 and CEA.

Authors:  Rosa Filiberti; Stefano Parodi; Roberta Libener; Giovanni Paolo Ivaldi; Pier Aldo Canessa; Donatella Ugolini; Barbara Bobbio; Paola Marroni
Journal:  Med Oncol       Date:  2013-03-27       Impact factor: 3.064

7.  Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.

Authors:  Weigen Yao; Hanqing Yang; Guolai Huang; Yang Yan; Honglin Wang; Dongfang Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Differential diagnosis of pleural mesothelioma using Logic Learning Machine.

Authors:  Stefano Parodi; Rosa Filiberti; Paola Marroni; Roberta Libener; Giovanni Paolo Ivaldi; Michele Mussap; Enrico Ferrari; Chiara Manneschi; Erika Montani; Marco Muselli
Journal:  BMC Bioinformatics       Date:  2015-06-01       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.